Advanced in Mikulicz Disease

Dr. Dennis H. Kraus

Otolaryngology
1275 York Ave, 
New York, NY 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Mikulicz Disease
1275 York Ave, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dennis Kraus is an Otolaryngologist in New York, New York. Dr. Kraus is rated as an Advanced provider by MediFind in the treatment of Mikulicz Disease. His top areas of expertise are Salivary Gland Tumors, Sinus Cancer, Olfactory Neuroblastoma, Gastrostomy, and Endoscopic Transnasal Transsphenoidal Surgery.

His clinical research consists of co-authoring 166 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Otolaryngology
Licenses
Otolaryngology in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

1275 York Ave, New York, NY 10021

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Enrollment Status: Recruiting
Publish Date: September 19, 2025
Intervention Type: Drug, Other, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929 Photoimmunotherapy Versus Physician's Choice Standard of Care for the Treatment of Locoregional, Recurrent Head and Neck Squamous Cell Carcinoma in Patients Who Have Failed or Progressed On or After at Least Two Lines of Therapy, of Which at Least One Line Must Be Systemic Therapy
A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929 Photoimmunotherapy Versus Physician's Choice Standard of Care for the Treatment of Locoregional, Recurrent Head and Neck Squamous Cell Carcinoma in Patients Who Have Failed or Progressed On or After at Least Two Lines of Therapy, of Which at Least One Line Must Be Systemic Therapy
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Drug, Combination product
Study Drugs: ASP-1929, Docetaxel, Cetuximab, Methotrexate, Paclitaxel
Study Phase: Phase 3
A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy With the IRX 2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity
A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy With the IRX 2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Drug, Dietary supplement, Biological
Study Drugs: IRX-2, Cyclophosphamide, Indomethacin, Omeprazole
Study Phase: Phase 2
Phase I Trial of Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck
Phase I Trial of Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck
Enrollment Status: Terminated
Publish Date: November 03, 2021
Intervention Type: Drug
Study Drug: Cetuximab
Study Phase: Phase 1
View 3 Less Clinical Trials

166 Total Publications

The structure of liquid carbon elucidated by in situ X-ray diffraction.
The structure of liquid carbon elucidated by in situ X-ray diffraction.
Journal: Nature
Published: November 19, 2024
Similar Doctors
Distinguished in Mikulicz Disease
Dr. Eric M. Genden
Otolaryngology
Distinguished in Mikulicz Disease
Dr. Eric M. Genden
Otolaryngology

Icahn School Of Medicine At Mount Sinai

5 E 98th St, Fl 8, 
New York, NY 
 (1.7 miles away)
212-731-6870
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eric Genden is an Otolaryngologist in New York, New York. Dr. Genden is rated as a Distinguished provider by MediFind in the treatment of Mikulicz Disease. His top areas of expertise are Human Papillomavirus Infection, Parathyroid Adenoma, Parathyroid Cancer, Laryngectomy, and Glossectomy.

Distinguished in Mikulicz Disease
Dr. Dev P. Kamdar
Otolaryngology
Distinguished in Mikulicz Disease
Dr. Dev P. Kamdar
Otolaryngology

North Shore-Lij Medical PC

300 Community Dr, 
Manhasset, NY 
 (13.3 miles away)
516-562-3058
Languages Spoken:
English
See accepted insurances

Dev Kamdar is an Otolaryngologist in Manhasset, New York. Dr. Kamdar is rated as a Distinguished provider by MediFind in the treatment of Mikulicz Disease. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Mikulicz Disease, Gastrostomy, and Laryngectomy.

Distinguished in Mikulicz Disease
Dr. Douglas K. Frank
Otolaryngology
Distinguished in Mikulicz Disease
Dr. Douglas K. Frank
Otolaryngology

North Shore-Lij Medical PC

430 Lakeville Rd, 
New Hyde Park, NY 
 (13.2 miles away)
718-470-7550
Languages Spoken:
English
See accepted insurances

Douglas Frank is an Otolaryngologist in New Hyde Park, New York. Dr. Frank is rated as a Distinguished provider by MediFind in the treatment of Mikulicz Disease. His top areas of expertise are Tongue Cancer, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Glossectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kraus's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 30 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile